601688:SSEHuatai Securities Co., Ltd. Class A Analysis
Data as of 2026-03-14 - not real-time
CN¥19.65
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at CNY 19.65, just above the calculated support level of CNY 19.59 and well below the 20‑day SMA of CNY 21.17. A bearish MACD (‑0.79 line vs ‑0.67 signal) and an RSI of 25.8 signal that momentum remains negative but also suggest the market may be oversold. Volume is increasing, indicating renewed buying interest despite the neutral trend direction. The beta of 0.30 points to very low sensitivity to broader market moves, while the 30‑day volatility of 24% reflects a relatively choppy price environment. The price sits below the 50‑day SMA (CNY 22.50) and well under the resistance at CNY 22.92, reinforcing the short‑term downside bias.
On the valuation side, the forward PE of 10.25 and trailing PE of 11.98 are markedly below the industry average PE of 16.35, suggesting the stock is undervalued relative to peers. A dividend yield of 2.65% and a modest payout ratio of 31.7% provide income appeal, though operating cash flow is negative (‑CNY 16.2 bn) and debt‑to‑equity exceeds 200%, flagging sustainability concerns. The company’s book‑value per share of CNY 16.78 translates to a price‑to‑book of 1.17, indicating a modest premium over net assets. Strong cash reserves (CNY 590 bn) offset the heavy debt load, but the negative free cash flow underscores the need for earnings improvement. The sector’s capital‑markets exposure carries medium regulatory and geographic risk, while the low beta and high trading volume mitigate liquidity concerns. Overall, the blend of attractive valuation and dividend income is tempered by earnings contraction and leverage, pointing to a cautious but potentially rewarding investment horizon.
On the valuation side, the forward PE of 10.25 and trailing PE of 11.98 are markedly below the industry average PE of 16.35, suggesting the stock is undervalued relative to peers. A dividend yield of 2.65% and a modest payout ratio of 31.7% provide income appeal, though operating cash flow is negative (‑CNY 16.2 bn) and debt‑to‑equity exceeds 200%, flagging sustainability concerns. The company’s book‑value per share of CNY 16.78 translates to a price‑to‑book of 1.17, indicating a modest premium over net assets. Strong cash reserves (CNY 590 bn) offset the heavy debt load, but the negative free cash flow underscores the need for earnings improvement. The sector’s capital‑markets exposure carries medium regulatory and geographic risk, while the low beta and high trading volume mitigate liquidity concerns. Overall, the blend of attractive valuation and dividend income is tempered by earnings contraction and leverage, pointing to a cautious but potentially rewarding investment horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price near support
- bearish MACD
- oversold RSI
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- undervalued PE vs industry
- attractive dividend yield
- low beta defensive profile
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- secular growth of Chinese capital markets
- high cash reserves offsetting leverage
- regulatory and debt headwinds
Key Metrics & Analysis
Financial Health
Revenue Growth-7.10%
Profit Margin35.99%
P/E Ratio12.0
ROE7.92%
ROA1.65%
Debt/Equity214.30
P/B Ratio1.2
Op. Cash FlowCN¥-16178422784
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI25.8
SupportCN¥19.59
ResistanceCN¥22.92
MA 20CN¥21.17
MA 50CN¥22.50
MA 200CN¥20.76
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
GradeUndervalued
TypeValue
Dividend Yield2.65%
Risk Assessment
Beta0.30
Volatility24.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.